Sensus Healthcare Q2 2024 GAAP EPS $0.10 Beats $0.02 Estimate, Sales $9.239M Beat $7.002M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sensus Healthcare (NASDAQ:SRTS) reported Q2 2024 GAAP EPS of $0.10, significantly beating the analyst estimate of $0.02. The company also reported sales of $9.239 million, surpassing the $7.002 million estimate. This represents a 600% increase in EPS and a 104.09% increase in sales compared to the same period last year.
August 08, 2024 | 9:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sensus Healthcare reported Q2 2024 GAAP EPS of $0.10, beating the analyst estimate of $0.02 by 400%. Sales of $9.239 million also exceeded the $7.002 million estimate, marking a 104.09% increase over the same period last year.
The significant beat on both EPS and sales estimates, along with substantial year-over-year growth, is likely to positively impact SRTS stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100